Skip to main content
. 2013 Jan;29(1):136–141. doi: 10.1089/aid.2012.0102

Table 3.

Frequency of Major ARV Mutations Among HIV-Positive Prisoners ever Exposed to an ARV During Incarceration (EPADI) with Genotype Testing in North Carolina Department of Corrections, October 2006 - February 2010 (n=329)

NNRTI N % (95% CI) NRTI N % (95% CI) PI N % (95% CI)
K103N 52 15.81 (12.0,20.2) M184V 47 14.29 (10.7,18.5) I50V 12 3.65 (1.9,6.3)
Y181C 9 2.74 (1.3,5.1) M41L 16 4.86 (2.8,7.8) L90M 7 2.13 (0.9,4.3)
G190S 4 1.22 (0.3,3.1) K65R 8 2.43 (1.1,4.7) I54V 6 1.82 (0.7,3.9)
K101E 4 1.22 (0.3,3.1) M184I 7 2.13 (0.9,4.3) M46I 6 1.82 (0.7,3.9)
K103S 4 1.22 (0.3,3.1) L74V 6 1.82 (0.8,3.9) I84V 5 1.52 (0.5,3.5)
G190A 3 0.91 (0.2,2.6) L74I 5 1.52 (0.5,3.5) V82A 5 1.52 (0.5,3.5)
K101P 3 0.91 (0.2,2.6) T215F 5 1.52 (0.5,3.5) N88D 4 1.22 (0.3,3.1)
K238T 3 0.91 (0.2,2.6) T215Y 5 1.52 (0.5,3.5) D30N 3 0.91 (0.2,2.6)
L100I 3 0.91 (0.2,2.6) T69ADNT 3 0.91 (0.2,2.6) I54L 2 0.61 (0.1,2.2)
Y188L 3 0.91 (0.2,2.6) T69NT 2 0.61 (0.1,2.2) V32I 2 0.61 (0.1,2.2)
V106M 2 0.61 (0.1,2.2)            

Mutations with only a single occurrence were M230L, V106A, T69AT, V75T, Y115F, F53L, G48V, G73S, G73T, I47V, I50L, L23I, M46L, and V82T.

NNRTI, nonnucleoside reverse transcriptase inhibitors; NRTI, nucleoside reverse transcriptase inhibitors; PI, protease inhibitors.